ICU Medical (NASDAQ:ICUI) Share Price Crosses Above 50-Day Moving Average – Time to Sell?

Shares of ICU Medical, Inc. (NASDAQ:ICUI) passed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $164.97 and traded as high as $166.65. ICU Medical shares last traded at $166.39, with a volume of 156,425 shares changing hands.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ICUI. Needham & Company LLC boosted their target price on shares of ICU Medical from $165.00 to $187.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Raymond James Financial reiterated a “strong-buy” rating and set a $200.00 price target on shares of ICU Medical in a research report on Friday, August 7th. KeyCorp lifted their price objective on shares of ICU Medical from $164.00 to $182.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Weiss Ratings upgraded shares of ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Finally, Zacks Research downgraded ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 28th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, ICU Medical currently has an average rating of “Moderate Buy” and an average target price of $192.80.

ICU Medical Trading Down 2.9%

The business has a fifty day moving average of $164.22 and a 200-day moving average of $148.89. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.21 and a current ratio of 2.43. The company has a market capitalization of $4.09 billion, a P/E ratio of 138.80, a PEG ratio of 2.12 and a beta of 0.86.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 EPS for the quarter, beating analysts’ consensus estimates of $1.91 by $0.46. The business had revenue of $547.88 million during the quarter, compared to analyst estimates of $533.44 million. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. ICU Medical’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.10 EPS. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Analysts anticipate that ICU Medical, Inc. will post 7.22 earnings per share for the current fiscal year.

Insider Buying and Selling at ICU Medical

In related news, insider Ben Sousa sold 2,250 shares of the stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $178.32, for a total value of $401,220.00. Following the completion of the sale, the insider directly owned 3,076 shares of the company’s stock, valued at approximately $548,512.32. This represents a 42.25% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Virginia Sanzone sold 4,856 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $168.69, for a total transaction of $819,158.64. Following the transaction, the vice president directly owned 14,604 shares in the company, valued at $2,463,548.76. The trade was a 24.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 21,830 shares of company stock valued at $3,905,003 in the last three months. Insiders own 2.10% of the company’s stock.

Institutional Trading of ICU Medical

Several hedge funds have recently added to or reduced their stakes in ICUI. Allworth Financial LP bought a new stake in shares of ICU Medical in the 2nd quarter worth approximately $26,000. Versant Capital Management Inc grew its holdings in ICU Medical by 26.2% during the third quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier’s stock valued at $50,000 after purchasing an additional 65 shares during the period. Public Employees Retirement System of Ohio purchased a new stake in ICU Medical in the second quarter worth $51,000. Rockefeller Capital Management L.P. increased its position in ICU Medical by 21.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock worth $117,000 after buying an additional 146 shares during the last quarter. Finally, Nykredit A S purchased a new stake in ICU Medical in the second quarter worth $135,000. Institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures and sells medical devices and systems used in infusion therapy, critical care and oncology. Its products are designed to support the delivery of fluids, medications and nutrition while helping healthcare providers improve safety and efficiency in clinical settings.

The company’s portfolio includes infusion pumps, dedicated and non-dedicated administration sets, needle-free connectors, intravenous solutions and other infusion consumables. ICU Medical also offers products for critical care monitoring and vascular access, as well as closed-system transfer devices and related technologies used in the preparation and administration of hazardous drugs.

Founded in 1984, ICU Medical has expanded through internal development and acquisitions, including the acquisition of Hospira’s infusion systems business in 2017 and Smiths Medical in 2022.